Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder

NCT01217775 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
1400
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pherin Pharmaceuticals, Inc.